{"id":6195,"date":"2026-11-10T17:14:47","date_gmt":"2026-11-10T15:14:47","guid":{"rendered":"https:\/\/nefro-nl.nl\/?post_type=nefro_study&#038;p=6195"},"modified":"2026-11-11T18:09:23","modified_gmt":"2026-11-11T16:09:23","slug":"sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation","status":"publish","type":"nefro_study","link":"https:\/\/nefro-nl.nl\/en\/study\/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation\/","title":{"rendered":"SACK: apixaban in stage 5 CKD and atrial fibrillation"},"content":{"rendered":"","protected":false},"template":"","nefro_condition":[107],"nefro_status":[80],"nefro_initiator":[89],"nefro_design":[77],"nefro_intervention":[79],"nefro_centre":[73],"class_list":["post-6195","nefro_study","type-nefro_study","status-publish","hentry","nefro_condition-chronic-kidney-disease-and-dialysis","nefro_status-open-for-recruitment","nefro_initiator-iit","nefro_design-phase-iii","nefro_intervention-drug-treatment","nefro_centre-sint-antonius-ziekenhuis"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SACK: apixaban in stage 5 CKD and atrial fibrillation | NEFRO-NL<\/title>\n<meta name=\"description\" content=\"Patients with stage 5 chronic kidney disease and atrial fibrillation face a high risk of both thromboembolic and bleeding complications, while evidence to\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nefro-nl.nl\/en\/study\/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SACK: apixaban in stage 5 CKD and atrial fibrillation | NEFRO-NL\" \/>\n<meta property=\"og:description\" content=\"Patients with stage 5 chronic kidney disease and atrial fibrillation face a high risk of both thromboembolic and bleeding complications, while evidence to\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nefro-nl.nl\/en\/study\/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation\/\" \/>\n<meta property=\"og:site_name\" content=\"NEFRO-NL\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-11T16:09:23+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nefro-nl.nl\\\/en\\\/study\\\/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation\\\/\",\"url\":\"https:\\\/\\\/nefro-nl.nl\\\/en\\\/study\\\/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation\\\/\",\"name\":\"SACK: apixaban in stage 5 CKD and atrial fibrillation | NEFRO-NL\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nefro-nl.nl\\\/en\\\/#website\"},\"datePublished\":\"2026-11-10T15:14:47+00:00\",\"dateModified\":\"2026-11-11T16:09:23+00:00\",\"description\":\"Patients with stage 5 chronic kidney disease and atrial fibrillation face a high risk of both thromboembolic and bleeding complications, while evidence to\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nefro-nl.nl\\\/en\\\/study\\\/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nefro-nl.nl\\\/en\\\/study\\\/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nefro-nl.nl\\\/en\\\/study\\\/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nefro-nl.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SACK: apixaban in stage 5 CKD and atrial fibrillation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nefro-nl.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/nefro-nl.nl\\\/en\\\/\",\"name\":\"NEFRO-NL\",\"description\":\"To promote scientific research related to kidney diseases (nephrology) in the Netherlands\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nefro-nl.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SACK: apixaban in stage 5 CKD and atrial fibrillation | NEFRO-NL","description":"Patients with stage 5 chronic kidney disease and atrial fibrillation face a high risk of both thromboembolic and bleeding complications, while evidence to","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nefro-nl.nl\/en\/study\/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation\/","og_locale":"en_US","og_type":"article","og_title":"SACK: apixaban in stage 5 CKD and atrial fibrillation | NEFRO-NL","og_description":"Patients with stage 5 chronic kidney disease and atrial fibrillation face a high risk of both thromboembolic and bleeding complications, while evidence to","og_url":"https:\/\/nefro-nl.nl\/en\/study\/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation\/","og_site_name":"NEFRO-NL","article_modified_time":"2026-11-11T16:09:23+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nefro-nl.nl\/en\/study\/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation\/","url":"https:\/\/nefro-nl.nl\/en\/study\/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation\/","name":"SACK: apixaban in stage 5 CKD and atrial fibrillation | NEFRO-NL","isPartOf":{"@id":"https:\/\/nefro-nl.nl\/en\/#website"},"datePublished":"2026-11-10T15:14:47+00:00","dateModified":"2026-11-11T16:09:23+00:00","description":"Patients with stage 5 chronic kidney disease and atrial fibrillation face a high risk of both thromboembolic and bleeding complications, while evidence to","breadcrumb":{"@id":"https:\/\/nefro-nl.nl\/en\/study\/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nefro-nl.nl\/en\/study\/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nefro-nl.nl\/en\/study\/sack-apixaban-in-stage-5-ckd-and-atrial-fibrillation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nefro-nl.nl\/en\/"},{"@type":"ListItem","position":2,"name":"SACK: apixaban in stage 5 CKD and atrial fibrillation"}]},{"@type":"WebSite","@id":"https:\/\/nefro-nl.nl\/en\/#website","url":"https:\/\/nefro-nl.nl\/en\/","name":"NEFRO-NL","description":"To promote scientific research related to kidney diseases (nephrology) in the Netherlands","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nefro-nl.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/nefro-nl.nl\/en\/wp-json\/wp\/v2\/nefro_study\/6195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nefro-nl.nl\/en\/wp-json\/wp\/v2\/nefro_study"}],"about":[{"href":"https:\/\/nefro-nl.nl\/en\/wp-json\/wp\/v2\/types\/nefro_study"}],"version-history":[{"count":2,"href":"https:\/\/nefro-nl.nl\/en\/wp-json\/wp\/v2\/nefro_study\/6195\/revisions"}],"predecessor-version":[{"id":6224,"href":"https:\/\/nefro-nl.nl\/en\/wp-json\/wp\/v2\/nefro_study\/6195\/revisions\/6224"}],"wp:attachment":[{"href":"https:\/\/nefro-nl.nl\/en\/wp-json\/wp\/v2\/media?parent=6195"}],"wp:term":[{"taxonomy":"nefro_condition","embeddable":true,"href":"https:\/\/nefro-nl.nl\/en\/wp-json\/wp\/v2\/nefro_condition?post=6195"},{"taxonomy":"nefro_status","embeddable":true,"href":"https:\/\/nefro-nl.nl\/en\/wp-json\/wp\/v2\/nefro_status?post=6195"},{"taxonomy":"nefro_initiator","embeddable":true,"href":"https:\/\/nefro-nl.nl\/en\/wp-json\/wp\/v2\/nefro_initiator?post=6195"},{"taxonomy":"nefro_design","embeddable":true,"href":"https:\/\/nefro-nl.nl\/en\/wp-json\/wp\/v2\/nefro_design?post=6195"},{"taxonomy":"nefro_intervention","embeddable":true,"href":"https:\/\/nefro-nl.nl\/en\/wp-json\/wp\/v2\/nefro_intervention?post=6195"},{"taxonomy":"nefro_centre","embeddable":true,"href":"https:\/\/nefro-nl.nl\/en\/wp-json\/wp\/v2\/nefro_centre?post=6195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}